Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

Por Peral, Carmen, Sánchez-Ballester, Francisco, García-Mediero, José M, Ramos, Jaime, Rejas, Javier
Publicado no Clinicoecon Outcomes Res (2016)

Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain

Por Sánchez-Cenizo, Laura, Aller, Javier, Martínez-Sesmero, José Manuel, Mir, Nuria, Peral, Carmen, Rubio-Rodríguez, Darío, Rubio-Terrés, Carlos
Publicado no Clinicoecon Outcomes Res (2019)

Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review

Por Puig, Lluís, Fernández-Freire, Lourdes Rodríguez, Burgos-Pol, Ramón, Gomez, Ismael, Peral, Carmen, Gomez, Susana, Rebollo Laserna, Francisco José
Publicado no Dermatol Ther (Heidelb) (2019)

The cost‐effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen dia...

Por Azanza, José Ramón, Grau, Santiago, Vázquez, Lourdes, Rebollo, Pablo, Peral, Carmen, López‐Ibáñez de Aldecoa, Alejandra, López‐Gómez, Vanessa
Publicado no Mycoses (2020)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in...

Por Grau, Santiago, Azanza, Jose Ramon, Ruiz, Isabel, Vallejo, Carlos, Mensa, Josep, Maertens, Johan, Heinz, Werner J, Barrueta, Jon Andoni, Peral, Carmen, Mesa, Francisco Jesús, Barrado, Miguel, Charbonneau, Claudie, Rubio-Rodríguez, Darío, Rubio-Terrés, Carlos
Publicado no Clinicoecon Outcomes Res (2016)